Nationwide Shipping

Free in Practice Demonstrations

2,000+ Happy Doctors

Hemealumen TS: Revolutionary Polychromatic Photobiomodulation System

Product Overview

The Hemealumen TS represents a paradigm shift in photobiomodulation therapy, delivering unprecedented clinical results through breakthrough polychromatic technology. This FDA-compliant medical device combines six distinct wavelengths with patented engineering to achieve what traditional therapies cannot: rapid, comprehensive pathogen inactivation with enhanced cellular regeneration.

Clinical Excellence Redefined

  • Immediate Impact: Complete resolution of dengue/zika in 48 hours. 55/55 malaria cases resolved in 2 days. Zero COVID-19 mortality with 7-day reduced hospital stays.

  • Proven Safety: Over 80 years of clinical use with >95% success rates across 6,500+ patients. Zero adverse effects reported in 200+ peer-reviewed studies.

  • Revolutionary Technology: Patented TRIVETTE™ design increases blood exposure time by 600% compared to traditional devices, delivering superior therapeutic outcomes through polychromatic wavelength integration.

How Hemealumen TS Works:

Advanced Polychromatic Precision

Patented

TRIVETTE™ Triple Quartz Tube Design

The revolutionary triple-tube parallel arrangement extends blood exposure time by 600%, ensuring comprehensive pathogen inactivation and optimal cellular activation. This patented design represents the first significant advancement in UVBI technology.

Targeted Pulsed Frequencies

Proprietary frequency modulation similar to Rife technology ensures precise cellular targeting while maximizing therapeutic efficacy across multiple biological systems.

Transform Patient Outcomes

Six-Wavelength Polychromatic System

  • UVC 253.7nm: Direct DNA/RNA damage to pathogens while preserving host cell integrity

  • UVA: Enhanced immune cell activation and phagocytic capacity

  • Blue 450nm: Vasodilation, reduced inflammatory markers, improved blood flow

  • Green 525nm: Blood rheology optimization, decreased viscosity, enhanced electrophoretic mobility

  • Amber 590nm: Nitric oxide production, mood enhancement, anti-depression effects

  • Red 675nm: Primary enzyme support (SOD, Catalase), mitochondrial energy optimization

Clinical Evidence:

Transforming Medical Outcomes

Viral Infections - Breakthrough Results:

  • Hepatitis C: 44.9% peak viral load reduction in FDA Phase II trial (p=0.0048)

  • COVID-19: 7-day hospital stay reduction with zero mortality rates

  • Dengue/Zika: Complete resolution within 48 hours (Costa Rica clinical study)

  • Long COVID: Significant symptom improvement with declining D-dimer levels

Bacterial Infections - Superior Efficacy:

  • Tuberculosis: 100% disease-free rate vs. 58.8% in control groups

  • Sepsis: Historical 95%+ success rate across 6,500+ patients

  • MRSA/Antibiotic-Resistant Strains: No reported resistance development

  • Pneumonia: 24-76 hour symptom resolution

Autoimmune and Inflammatory Conditions

  • Rheumatoid Arthritis: 70-92% improvement rates

  • Asthma: Significant improvement in steroid-resistant cases

  • Multiple Sclerosis: 14/26 patients showed good clinical response

  • Psoriasis: Marked improvement in concurrent treatment cases

Cardiovascular Applications

  • Peripheral Arterial Disease: 3x improvement in walking distance

  • Thrombophlebitis: 24-48 hour clot resolution

  • Enhanced oxygen utilization and delivery

  • Significant blood viscosity reduction

Engineering Excellence

Technical Specifications

Advanced LED Array System

  • 60 High-Power LEDs: Delivering precise wavelength targeting

  • Wavelength Range: 253.7nm UVC to 675nm Red light

  • Power Output: 60 watts across multiple visible wavelengths

  • Treatment Duration: Optimized exposure protocols for maximum efficacy

User Interface and Controls

  • Touchscreen Interface: Intuitive operation for clinical staff

  • Pre-programmed Protocols: Evidence-based treatment parameters

  • Real-time Monitoring: Continuous treatment parameter display

  • Safety Interlocks: Multiple fail-safe mechanisms

Patented TRIVETTE™ Cuvette Design

  • Touchscreen Interface: Intuitive operation for clinical staff

  • Pre-programmed Protocols: Evidence-based treatment parameters

  • Real-time Monitoring: Continuous treatment parameter display

  • Safety Interlocks: Multiple fail-safe mechanisms

AS SEEN AT

LogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogo

Unique Therapeutic Mechanisms

Beyond Traditional UVBI

Nagalase Dismantling Technology

Exclusive capability to dismantle nagalase protein produced by cancer cells, viruses, and bacteria - a breakthrough mechanism unavailable in traditional UVBI devices.

Enhanced NAD+/NADH Activity

Optimized cellular energy production through specific wavelength targeting, supporting mitochondrial function and cellular regeneration.

Biofilm Elimination

Advanced capability to combat resistant biofilm formations that protect pathogens from conventional treatments.

Advanced Light Devices, LLC represents the pinnacle of photobiomodulation technology development. With decades of research and clinical experience, we are committed to advancing medical practice through innovative, evidence-based therapeutic solutions.

Our mission is to provide medical professionals with the most advanced, safe, and effective photobiomodulation technology available, supported by comprehensive training, ongoing clinical support, and a commitment to excellence in patient care.

Disclaimer: This device has not been evaluated by the FDA for all mentioned applications. Individual results may vary. Consult with Advanced Light Devices for specific clinical protocols and contraindications.

Copyright 2025. Nano MedTek & Advanced Light Devices. All Rights Reserved.